Alemtuzumab treatment has no adverse impact on sperm quality, quantity, or motility: A CARE-MS substudy
Margolin, D.H, Rizzo, M.A, Smith, G, Arnold, D.L, Cohen, J.A, Coles, A.J, Confavreux, C, Fox, E.J, Hartung, H.-P, Havrdova, E, Selmaj, K.W, Weiner, H.L, Brinar, V, Giovannoni, G, Miller, T.A, Stojanovic, M, Twyman, C.L, Lake, S.L, Panzara, M, Compston, D.A.S
Published in Journal of the neurological sciences (15.10.2013)
Published in Journal of the neurological sciences (15.10.2013)
Get full text
Journal Article
Adverse event profile of alemtuzumab over time in treatment-naïve patients with early, active relapsing–/INS;remitting multiple sclerosis (RRMS; CARE-MS I study)
Lycke, J, Arnold, D.L, Cohen, J.A, Coles, A.J, Confavreux, C, Fox, E.J, Hartung, H.-P, Havrdova, E, Selmaj, K.W, Weiner, H.L, Brinar, V, Giovannoni, G, Stojanovic, M, Lake, S.L, Margolin, D.H, Panzara, M, Compston, D.A.S
Published in Journal of the neurological sciences (15.10.2013)
Published in Journal of the neurological sciences (15.10.2013)
Get full text
Journal Article
Alemtuzumab improves visual outcomes in treatment-naïve patients with relapsing–/INS;remitting multiple sclerosis (RRMS): Analysis from the phase 3 CARE-MS I study
Balcer, L.J, Arnold, D.L, Cohen, J.A, Coles, A.J, Confavreux, C, Fox, E.J, Hartung, H.-P, Havrdova, E, Selmaj, K.W, Weiner, H.L, Brinar, V, Giovannoni, G, Stojanovic, M, Cinar, A, Margolin, D.H, Panzara, M, Compston, D.A.S
Published in Journal of the neurological sciences (15.10.2013)
Published in Journal of the neurological sciences (15.10.2013)
Get full text
Journal Article
Efficacy and safety of Alemtuzumab in treatment-naive patients with relapsing-remitting multiple sclerosis: Four-year follow-up of the Care-MS I study
Montalban, X, Inshasi, J.S, Coles, A.J, Hartung, H.P, Havrdova, E, Selmaj, K.W, Margolin, D.H, Palmer, J, Oyuela, P
Published in Multiple sclerosis and related disorders (01.11.2014)
Published in Multiple sclerosis and related disorders (01.11.2014)
Get full text
Journal Article
Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study
Kieseier, B.C, Sahraian, M.A, Coles, A.J, Hartung, H.P, Havrdova, E, Selmaj, K.W, Margolin, D.H, Palmer, J, Oyuela, P
Published in Multiple sclerosis and related disorders (01.11.2014)
Published in Multiple sclerosis and related disorders (01.11.2014)
Get full text
Journal Article
The immunological response to traumatic brain injury
Needham, E.J., Helmy, A., Zanier, E.R., Jones, J.L., Coles, A.J., Menon, D.K.
Published in Journal of neuroimmunology (15.07.2019)
Published in Journal of neuroimmunology (15.07.2019)
Get full text
Journal Article
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial
Coles, A J, Fox, E, Vladic, A, Gazda, S K, Brinar, V, Selmaj, K W, Skoromets, A, Stolyarov, I, Bass, A, Sullivan, H, Margolin, D H, Lake, S L, Moran, S, Palmer, J, Smith, M S, Compston, D A S
Published in Neurology (03.04.2012)
Published in Neurology (03.04.2012)
Get more information
Journal Article
A method to isolate and cryopreserve cerebrospinal fluid mononuclear cells from external ventricular drains to investigate immunological processes in acute brain injuries
Digby, R.J., Coppard, V., Mousa, H.S., Menon, D.K., Coles, A.J., Jones, J.L., Needham, E.J.
Published in Journal of immunological methods (01.12.2021)
Published in Journal of immunological methods (01.12.2021)
Get full text
Journal Article
P045 - Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study
Kieseier, B.C., Sahraian, M.A., Coles, A.J., Hartung, H.P., Havrdova, E., Selmaj, K.W., Margolin, D.H., Palmer, J., Oyuela, P.
Published in Multiple sclerosis and related disorders (01.11.2014)
Published in Multiple sclerosis and related disorders (01.11.2014)
Get full text
Journal Article
P058 - Efficacy and safety of Alemtuzumab in treatment-naive patients with relapsing-remitting multiple sclerosis: Four-year follow-up of the Care-MS I study
Montalban, X., Inshasi, J.S., Coles, A.J., Hartung, H.P., Havrdova, E., Selmaj, K.W., Margolin, D.H., Palmer, J., Oyuela, P.
Published in Multiple sclerosis and related disorders (01.11.2014)
Published in Multiple sclerosis and related disorders (01.11.2014)
Get full text
Journal Article
An investigation of auto-reactivity after head injury
Cox, A.L., Coles, A.J., Nortje, J., Bradley, P.G., Chatfield, D.A., Thompson, S.J., Menon, D.K.
Published in Journal of neuroimmunology (01.05.2006)
Published in Journal of neuroimmunology (01.05.2006)
Get full text
Journal Article
Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H
Paolillo, A, Coles, A J, Molyneux, P D, Gawne-Cain, M, MacManus, D, Barker, G J, Compston, D A, Miller, D H
Published in Neurology (11.09.1999)
Published in Neurology (11.09.1999)
Get more information
Journal Article